Phosphoric Acid Monododecyl Ester

Phosphoric Acid Monododecyl Ester

SCHEMBL3893034

CCCCCCCCCCCCOP(=O)([O-])[O-].[Ca+2]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphoric Acid Monododecyl Ester. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPAR3 Q9UBY5 8/20 0.59
▸ LPAR2 Q9HBW0 6/20 0.59
▸ LPAR1 Q92633 3/20 0.59
▸ AKT1 P31749 2/20 0.56
▸ CDC25A P30304 2/20 0.56
▸ LMNA P02545 1/20 0.56
▸ ESR1 P03372 1/20 0.56
▸ ADORA3 P0DMS8 1/20 0.56
▸ AGTR1 P30556 1/20 0.56
▸ ADRA1A P35348 1/20 0.56
▸ KCNH2 Q12809 1/20 0.56
▸ CYP3A4 P08684 1/20 0.50
▸ RECQL P46063 2/20 0.47
▸ GLA P06280 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ EPHX2 P34913 1/20 0.47
▸ BLM P54132 1/20 0.47
▸ TERT O14746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid Monodecyl Ester SCHEMBL28359660 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL28359607 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Hexadecyl Dihydrogen Phosphate SCHEMBL5680624 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL28355333 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL3784849 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Hexadecyl Dihydrogen Phosphate SCHEMBL483790 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL11255117 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL28359340 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
SCHEMBL28359276 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Phosphoric Acid Monotetradecyl Ester SCHEMBL28355509 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119913663-A Non-woven fabric for polylactic acid-polycaprolactone degradable woven bag and preparation method thereof 温州新奥达塑业有限公司 2025-05-02 — — CN claimed
CN-103289806-A Scratch-proof wire drawing oil JIANGSU HAIAN PETROCHEMICAL PLANT 2013-09-11 — — CN claimed
US-4707292-A ANIONIC SURFACTANTS, SHAMPOO KAO CORPORATION (JP) 1987-11-17 — — US claimed
CN-122005622-A Composition for improving, preventing or treating vaginitis or vulvitis comprising lactobacillus salivarius HHuMin-U 比菲德股份有限公司 2026-05-12 — — CN disclosed
US-12357553-B2 Composition for treating hair loss or promoting hair growth, comprising piperonylic acid Hesed Bio Co., Ltd. (KR) 2025-07-15 — — US disclosed
CN-119913663-A Non-woven fabric for polylactic acid-polycaprolactone degradable woven bag and preparation method thereof 温州新奥达塑业有限公司 2025-05-02 — — CN disclosed
CN-119913663-A Non-woven fabric for polylactic acid-polycaprolactone degradable woven bag and preparation method thereof 温州新奥达塑业有限公司 2025-05-02 — — CN disclosed
CN-115337242-B Traditional Chinese medicine composition, extract, preparation method and application thereof, cosmetics and medicines 上海如妍化妆品有限公司 2025-03-21 — — CN disclosed
US-20250025523-A1 COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASE COMPRISING SARGASSUM SERRATIFOLIUM EXTRACT Pukyong National University Industry- University Cooperation Foundation (KR) 2025-01-23 — — US disclosed
EP-3662907-B1 ANTI-AGING OR SKIN-REGENERATING COMPOSITION COMPRISING PIPERONYLIC ACID AS EFFECTIVE INGREDIENT HESED BIO CO LTD (KR) 2024-04-17 — — EP disclosed
CN-111315377-B Anti-aging or skin regenerating composition containing pyrrole acid as active ingredient 赫赛德生物有限公司 2024-04-02 — — CN disclosed
US-20020009472-A1 Cosmetics KYOWA HAKKO BIO CO., LTD. (JP) 2002-01-24 — — US disclosed
EP-1166767-A2 Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-01-02 — — EP disclosed
CN-1328813-A Cosmetics KYOWA HAKKO KOGY CO LTD (JP) 2002-01-02 — — CN disclosed
EP-1159952-A1 COSMETICS KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-12-05 — — EP disclosed
EP-0321786-B1 COMPOSITION FOR EXTERNAL APPLICATION KAO CORPORATION (JP) 1993-05-19 — — EP disclosed
EP-0321786-A2 Composition for external application KAO CORPORATION (JP) 1989-06-28 — — EP disclosed
US-4707292-A ANIONIC SURFACTANTS, SHAMPOO KAO CORPORATION (JP) 1987-11-17 — — US disclosed
US-4163018-A REACTING AN ALKYL PHOSPHATE WITH A GROUP 2A, ZINC, OR ALUMINUM HALIDE, NITRATE, OR SULFATE SAKAI CHEMICAL INDUSTRY COMPANY, LTD. (JP) 1979-07-31 — — US disclosed
US-4115209-A POLYMERIC MATRIX, CONDUCTIVE SUBSTRATE RESEARCH CORPORATION (US) 1978-09-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12357553-B2 Composition for treating hair loss or promoting hair growth, comprising piperonylic acid EGFR, PDGFA, HGF LPAR3 378/4885LPAR2 301/4885LPAR1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback